Lyrebird, an Australian startup focused on AI-powered medical scribe technology, has closed $12 million in new funding. The firm plans to use the capital to improve its business model. It’s looking to further integrate with Electronic Medical Record (EMR) systems and extend its reach into the United Kingdom and the Middle East. In early 2023, Kai Van Lieshout and Linus Talacko co-founded Lyrebird. Their mission is to cut the administrative burden placed on clinicians, so they can focus more of their time on patient care. Dr. Mandy Jiang is chief financial officer and executive director. Now under that leadership, the company is capturing more than 30,000 daily consultations in Australia and growing at a rate of more than 10% each month.

Revolutionizing Clinical Documentation with AI

Lyrebird’s main product is a platform that allows for automatic generation of clinical documentation based on patient-doctor conversations. This groundbreaking idea addresses one of the biggest pain points for healthcare staff. It takes them away from burdensome administrative functions, making them spend more time on non-patient care activities versus patient engagement. Lyrebird takes the work out of gathering data and creating documentation. This innovation frees up doctors’ time to see more patients and helps reduce wait times for all.

The platform provides brands with a transparent, live dashboard to track awareness, consideration, and perception metrics. As a result, this tool provides powerful insights into evolving market dynamics and patient needs. This holistic angle simplifies the documentation and offers a data-backed view into the current healthcare landscape.

In chronic health conditions, for example, Van Lieshout waited a grueling 12 months before even seeing a specialist. Underlying the development of Lyrebird were our experiences with these inefficiencies that began in school, and reverberated through the healthcare system. The platform that was born out of this collaboration is now assisting clinicians to document up to 30,000 specialist consultations a day in equalities Australia. Lyrebird’s platform just exploded, and this is moving really fast. It currently powers more than 10% more consults per month, serving as a testament to the increasing adoption and impact of its AI-powered solution.

Strategic Funding for Growth and Innovation

Lyrebird plans to invest the $12 million in funding strategically across three main areas. This investment will help accelerate the company’s rapid growth and expand their technological innovation. We’re putting a heavy focus of the investment on improving the product itself. This strategy enables Lyrebird’s AI medical scribe technology to remain at the vanguard of innovation. You will help improve the platform’s accuracy and reporting efficiency. Beyond that, you’ll need to be building new capabilities to adapt to the changing, complex requirements of healthcare practitioners.

Even further integration with EMR systems, including Best Practice and Gentu, are the next priorities on the radar for Lyrebird. Seamless integration with these systems is critical. Most importantly, it guarantees that this AI-generated documentation is actually available at your fingertips and easily integrates into current clinical workflows. This will continue the effort to reduce the amount of documentation required while making the process less administratively burdensome for healthcare professionals.

Lyrebird intends to use the funding to increase its expansion into the UK and the Middle East. This move is a big step for them to become a front-runner in the global health technology market. It provides Lyrebird with the opportunity to increase their reach. Finally, it’ll provide the necessary tools to help healthcare providers around the world increase their productivity and deliver better patient care.

Global Vision, Personal Mission

Lyrebird’s mission is inspired by a faith in protecting those that protect us all and devote their lives to serving others. Now, the company is pushing toward greater national adoption and increasing in-house technological development. It continues to stay true to its mission and vision of creating a better healthcare experience for providers and patients.

"Our vision is global, but our mission is personal: support the people who care for people." - Kevin Brown

Lyrebird’s platform tracks data across global markets, offering a lens into innovative healthcare trends and patient needs around the world. This import-oriented perspective informs the firm’s strategy choices. Importantly, it helps to ensure that their solutions are tailored to meet the distinctive challenges that healthcare providers face in every state across the country.